Disease: Hypercholesterolemia- autosomal dominant- type B
- A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE-1 insertion in LDLR
- A Clinical Case of Probable Sitosterolemia
- A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia
- A new non-human primate model of familial hypercholesterolemia
- A novel equation for the estimation of low-density lipoprotein cholesterol in the Saudi Arabian population: a derivation and validation study
- A retrospective study of people with familial hypercholesterolaemia in a Belgian lipid clinic
- A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia
- Achilles tendon ultrasonography in the clinical screening of familial hypercholesterolaemia - a cross-sectional analysis
- Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia
- Advances in familial hypercholesterolemia
- Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial
- Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
- Aortic valve and arterial calcification in patients with familial hypercholesterolemia
- Assessment of ethnic inequalities in diagnostic coding of familial hypercholesterolaemia (FH): A cross-sectional database study in Lambeth, South London
- Association of Clinical Characteristics With Familial Hypercholesterolaemia Variants in a Lipid Clinic Setting: A Case-Control Study
- Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia
- Beyond cardiovascular risk: Implications of Familial hypercholesterolemia on cognition and brain function
- Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?
- Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia
- Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study
- Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
- Cluster analysis and visualisation of electronic health records data to identify undiagnosed patients with rare genetic diseases
- Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease
- Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review
- CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing
- Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
- Determinants of lipid clinic referral and attendance in a multi-ethnic adult population in south London: a cross-sectional study
- Diagnosis of Familial Hypercholesterolemia in Children and Young Adults
- Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy
- Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
- Erste Gentherapie der familiären Hypercholesterinämie
- Establishing non-fasting reference values for plasma lipids levels based on age, sex, and puberty stage in a French-Canadian pediatric population
- Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
- Familial hypercholesterolemia
- Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners
- Familial Hypercholesterolemia and Our Family's Heart History: From Atherosclerosis and Angina to Awareness and Advocacy
- Familial hypercholesterolemia diagnostic challenge: Is Artificial Intelligence the key?
- Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study
- Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol
- Familial hypercholesterolemia with special focus on Japan
- Familial hypercholesterolemia, lipoprotein(a) and atherosclerosis
- Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial
- First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population
- Genetic association between vitamin D receptor gene and Saudi patients confirmed with Familial Hypercholesterolemia
- Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia
- Genetic identification of familial hypercholesterolemia within whole genome sequences in 6820 newborns
- Genetic Spectrum and Cascade Screening of Familial Hypercholesterolemia in Routine Clinical Setting in Hong Kong
- Genetic testing for familial hypercholesterolemia
- Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the question
- High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico
- Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia
- Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor
- If Action is Delayed, Is Survival Denied? Management of Severe Hypercholesterolemia Is Important and Urgent
- Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia
- Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
- Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia
- Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia
- International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia
- iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia
- Knowledge, attitude, and practice of physicians towards familial hypercholesterolaemia in north regions of Saudi Arabia
- Kommt das Screening auf familiäre Hypercholesterinämie?
- LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes
- LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
- LDLR gene rearrangements in Czech FH patients likely arise from one mutational event
- Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
- Liver transplantation for homozygous familial hypercholesterolemia: Cure for a genetic disease?
- Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand
- Longitudinal dynamics of circulating miRNAs in a swine model of familial hypercholesterolemia during early atherosclerosis
- Measuring Costs of Cardiovascular Disease Prevention for Patients with Familial Hypercholesterolemia in Administrative Claims Data
- Membrane Transporter of Serotonin and Hypercholesterolemia in Children
- Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry
- Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia
- OptiMo-LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues
- Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia
- Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry
- Plasma legumain in familial hypercholesterolemia: associations with statin use and cardiovascular risk markers
- Prevalence and factors associated with possible cases of familial hypercholesterolemia in Brazilian adults: a cross-sectional study
- Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study
- Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study
- Putative Pathogenic Variants of <em>ABCG5</em> and <em>ABCG8</em> of Sitosterolemia in Patients With Hyper-Low-Density Lipoprotein Cholesterolemia
- Real-world safety and efficacy of lomitapide in homozygous familial hypercholesterolemia: interim report of special-use survey in Japan
- Recapitulating familial hypercholesterolemia in a mouse model by knock-in patient-specific LDLR mutation
- Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United States
- Role of statins in the management of dyslipidaemia
- Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
- Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia
- Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
- Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?
- Spatial lipidomics of coronary atherosclerotic plaque development in a familial hypercholesterolemia swine model
- Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing
- The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction
- The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
- The Health History of First-Degree Relatives' Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia
- The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia
- Treatment of pediatric heterozygous familial hypercholesterolemia 7 years after the EAS recommendations: Real-world results from a large French cohort
- Universal paediatric screening for familial hypercholesterolaemia
- Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype
- Unveiling Familial Hypercholesterolemia-Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy
- Widespread xanthomas regression by personalized lipid lowering therapy in heterozygous familial hypercholesterolemia